HLA genotyping in synovial sarcoma: Identifying HLA-A*02 and its association with clinical outcome.
Evan Rosenbaum(Memorial Sloan Kettering Cancer Center), Sandra P. D’Angelo(Memorial Sloan Kettering Cancer Center), Ping Chi(Memorial Sloan Kettering Cancer Center), William D. Tap(Memorial Sloan Kettering Cancer Center), Mrinal M. Gounder(Memorial Sloan Kettering Cancer Center), Mark T.A. Donoghue(Memorial Sloan Kettering Cancer Center), Mark A. Dickson(Memorial Sloan Kettering Cancer Center), Benjamin A. Nacev(University of Pittsburgh), Li‐Xuan Qin(Memorial Sloan Kettering Cancer Center), Sujana Movva(Memorial Sloan Kettering Cancer Center), Noemi Simeone(Fondazione IRCCS Istituto Nazionale dei Tumori), Mary Louise Keohan(Roche (Switzerland)), Kenneth Seier(Memorial Sloan Kettering Cancer Center), Ciara M. Kelly(Memorial Sloan Kettering Cancer Center), Cristina R. Antonescu(Memorial Sloan Kettering Cancer Center), Chaitanya Bandlamudi(Memorial Sloan Kettering Cancer Center), Emily K. Slotkin(Memorial Sloan Kettering Cancer Center)
Cited by 4
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k